Advanced breakup-nucleon enhancement of deuteron-induced reaction cross sections

Following the EUROfusion PPPT-programme action for an advanced modeling approach of deuteron-induced reaction cross sections, as well as specific data evaluations in addition of the TENDL files, an assessment of the details and corresponding outcome for the latter option of TALYS for the breakup model has been carried out. The breakup enhancement obtained in the meantime within computer code TALYS, by using the evaluated nucleon-induced reaction data of TENDL-2019, is particularly concerned. Discussion of the corresponding results, for deuteron-induced reactions on $$^{58}$$ 58 Ni, $$^{96}$$ 96 Zr, and $$^{231}$$ 231 Pa target nuclei up to 200 MeV incident energy, includes limitations still existing with reference to the direct-reaction account.

Rhabdomyolysis Following Ad26.COV2.S COVID-19 Vaccination

We report the case of a 19-year-old male who complained of myalgia, muscle weakness, and darkened urine two days after receiving his Ad26.COV2.S (Johnson & Johnson, New Brunswick, New Jersey, United States) COVID-19 vaccination. Blood examination revealed an increased creatine kinase (CK) level, and his urinary dipstick tested positive for blood, indicative of acute rhabdomyolysis. Serum creatinine levels were normal. Rhabdomyolysis due to strenuous physical activity was ruled out and further diagnostics excluded an autoimmune cause. Under repeated treatment with intravenous fluid resuscitation (outpatient treatment), his symptoms resolved and peak CK levels of 44,180 U/L returned to almost normal levels within two weeks. Rhabdomyolysis is a rare, potentially fatal vaccine-induced reaction. Further research is needed to better understand the underlying pathomechanism and to investigate whether subcutaneous injection of vaccines may be able to prevent rhabdomyolysis.